Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.As of 25 May 2026, Unichem Laboratories share price is ₹359.50. The stock opened at ₹361.05, compared to its previous close of ₹370.85. During today's trading session, Unichem Laboratories share price moved in the range of ₹349.95 to ₹366.45, with an average price of ₹358.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹349.95 and a high of ₹366.45. On the performance front, Unichem Laboratories share price has declined by 20.49% over the last six months and is down 40.71% on a year-on-year basis.
The market capitalization of Unichem Laboratories is ₹2,621 Crs, with a P/E ratio of 8.9 and a dividend yield of 0.00%.